Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
about
Tocilizumab for rheumatoid arthritisAgranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritisEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs.Clinical safety of tocilizumab in rheumatoid arthritis.Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.Clinical pharmacology of tocilizumab for the treatment of systemic juvenile idiopathic arthritis.Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.Clinical pharmacology of tocilizumab for the treatment of polyarticular-course juvenile idiopathic arthritis.Clinical characteristics of influenza virus infection in juvenile idiopathic arthritis patients treated with tocilizumab.[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].Disentangling the effects of tocilizumab on neutrophil survival and function.
P2860
Q24234126-ACDBFFAF-2598-4DE5-9A57-587380202CFFQ28071389-64F1E890-41C7-4AE8-8760-CA5020720CD9Q34768442-9E5F97C3-81AC-41EA-B10D-1DF008F87C24Q37390458-C266FDDB-0467-4998-8A81-9B8292A2D73AQ37814417-BA704457-FCCA-435D-B539-539FE10DB189Q37960539-227795D5-130C-45E3-9EF3-53F6405D05F5Q38087694-45792682-693D-4F60-8436-67C690614774Q38268860-6F7FCE82-5E95-42CB-A9DD-DD22360AB9CBQ38411334-F760D2DD-17B7-4514-B08A-43D0844C4DF4Q38907789-802E12F1-324C-4A59-AD8D-252EBAE616B2Q40271226-3BBD7518-51A9-4B92-A0A1-7EAD252AF027Q41176187-8E73E1A1-A2D8-42FC-B8C7-2266722F61CAQ48044670-15F9ACCE-BA15-4654-B34A-017872417945
P2860
Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@en
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@nl
type
label
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@en
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@nl
prefLabel
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@en
Blockade of interleukin 6 sign ...... nts with rheumatoid arthritis.
@nl
P2093
P356
P1476
Blockade of interleukin 6 sign ...... ents with rheumatoid arthritis
@en
P2093
Ichiro Nakamura
Katsumi Ito
Yasunori Omata
P304
P356
10.3899/JRHEUM.080930
P407
P577
2009-02-01T00:00:00Z